Skip to content
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

LEVERAGED MEGA-BUYOUTS BACK IN FASHION

With the COVID War ending and the economy reviving, the “Bigs” are ready to shower cash on leveraged buyouts priced at $10 billion or more. 
CVC Capital Partners has bid $20 billion for Toshiba, the Japanese conglomerate that makes everything from hard drives to escalators. Medline Industries has hired Goldman Sachs to find it a buyer, the Wall Street Journal reported, a deal that could be priced at $30 billion.
From 2005 through 2007, private equity firms made 18 deals, each worth at least $10 billion, according to the WSJ; in the more than 13 years since, only ten have happened.
Now asset managers have $1.6 trillion in cash in their pockets, according to Preqin, a research firm. Sinking the money into headline-grabbing deals is a way not only to reach for big returns but also to establish themselves as major-league players, analysts say.
The firms might have even more money than that at their disposal, Jonathan Karen, a partner in the deal-making law firm Simpson Thacker & Bartlett, told the WSJ.
“There’s this shadow capital” that equity firms can call up from private investors, he explained. The firms give special clients the chance to invest directly into deals instead of running their money through the investment firm and paying the attendant fees.
“If you have a $10-billion fund, you might have $5 billion – or even another $10 billion – waiting in the wings,” he said.
The amount of leverage in the deals, as well as the price, is raising eyebrows.
For deals in 2020, the two-year trailing average debt multiple was seven times earnings before interest, taxes, depreciation, and amortization (EBITA), compared to 6.4 times in 2007, according to an analysis by McKinsey & Co.
Banks frown on banks lending to buyout deals with EBITA above six.
Another measure – the two-year average purchase-price multiple – has reached a record 12.8 times EBITA; in 2007, it was 9.4, McKinsey found.
TREND FORECAST: First, the “Bigs” continue to get bigger as they borrow cheap money to accelerate their takeovers. 
Second, as interest rates rise, not only will the leveraged buyouts slow down as it becomes more expensive to borrow money, the higher rates go, the more difficult it will be for them to service debt payments.